Immunotherapy before surgery shows remarkable cancer-free durability for certain colorectal cancers
Patients with a specific type of bowel cancer treated with immunotherapy before surgery remained cancer free 33 months after treatment, results of a clinical trial show.
A new approach to blood tests for cancer yields promising results
A new type of blood test is showing promise of being able to detect multiple liver diseases including cancer by examining fragments of DNA that circulate in the blood.
Could a vaccine prevent pancreatic cancer?
A small clinical trial showed proof of concept of vaccine prevention of pancreatic cancer in high-risk individuals. (Image generated by WIX AI) CANCER DIGEST – July 19, 2026 – That’s the question asked by researchers led by Neeha Zaidi, MD, at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University. Approximately 10 percent of pancreatic cancers are associated with genetic predisposition caused by mutations in specific cancer susceptibility genes that are pa
Breakthrough drug daraxonrasib doubles survival in patients with advanced pancreatic cancer
In a clinical trial, an experimental oral targeted medication nearly doubled overall survival in pancreatic cancer patients with a specific genetic mutation, compared to standard chemotherapy.
Newly discovered virus linked to colorectal cancer
Scientists have discovered a new and previously undescribed virus
that infects gut bacteria in patients with colorectal cancer.
Immunotherapy before surgery prolongs cancer-free survival among certain colon cancer patients
atients given a course of immunotherapy prior to surgery for colon cancer remain cancer-free nearly three years later.
